BALAMINES.BOBALAMINES.BOBSE
Loading
EBITDA Over TimeContracting
Percentile Rank71
3Y CAGR-25.3%
5Y CAGR+7.4%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-25.3%/yr
vs +36.0%/yr prior
5Y CAGR
+7.4%/yr
Recent deceleration
Acceleration
-61.3pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$2.65B-24.9%
2024$3.53B-43.4%
2023$6.24B-1.9%
2022$6.36B+67.6%
2021$3.79B+104.1%
2020$1.86B-4.9%
2019$1.95B+5.2%
2018$1.86B+22.4%
2017$1.52B+21.2%
2016$1.25B-